Abbott under FDA scrutiny for psoriasis drug
are. The agency, however, has in recent years stepped up its scrutiny of the safety and efficacy of drugs and increasingly orders more study in clinical trials, particularly for safety risks to the heart. The news hit the company’s stock. The price
Moreover Technologies – Search results for… drugs – 30 of 678 returned
Leave a Reply
You must be logged in to post a comment.